Dive Brief: Rapport Therapeutics’ market value doubled on Monday after the neurology-focused drugmaker unveiled mid-stage study results for an experim...

Combining Summit Therapeutics and Akeso’s closely watched cancer drug with chemotherapy didn’t help people with lung cancer live longer than chemo alo...

Dive Brief: Pfizer and partner BioNTech said Monday their updated COVID-19 booster spurred strong immune responses against currently circulating coron...

Drug developers from around the world rang in a new era of sleep medicine Monday, as data from a series of clinical trials show narcolepsy can be effe...

Dive Brief: BioNTech’s experimental bispecific cancer drug pumitamig helped shrink tumors in three-quarters of people with small cell lung cancer who...

Artificial intelligence (AI) has quietly become a part of our daily lives – through personalized recommendations, virtual assistants, or smart devices...

Modern obesity trials are inherently complex, but the momentum behind these therapeutics has never been greater. With over $30 billion invested global...

Biomarker testing is foundational to successful targeted and immunotherapy development. From discovery to commercialization, strategic biomarker integ...

A newly launched startup is the latest young company to build itself around a drug discovered in Chinese laboratories. Hengrui Pharma on Friday said i...

Today, a brief rundown of news involving the Food and Drug Administration and Gilead Sciences, as well as updates from AC Immune, Agios Pharmaceutical...